TrialStem cell research & therapy2025

Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.

Joon Seok et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.